Therapeutic strategy for oncovirus-mediated oral cancer: A comprehensive review

Biomed Pharmacother. 2023 Sep:165:115035. doi: 10.1016/j.biopha.2023.115035. Epub 2023 Jun 24.

Abstract

Oral cancer is a neoplastic disorder of the oral cavities, including the lips, tongue, buccal mucosa, and lower and upper gums. Oral cancer assessment entails a multistep process that requires deep knowledge of the molecular networks involved in its progression and development. Preventive measures including public awareness of risk factors and improving public behaviors are necessary, and screening techniques should be encouraged to enable early detection of malignant lesions. Herpes simplex virus (HSV), human papillomavirus (HPV), Epstein-Barr virus (EBV), and Kaposi sarcoma-associated herpesvirus (KSHV) are associated with other premalignant and carcinogenic conditions leading to oral cancer. Oncogenic viruses induce chromosomal rearrangements; activate signal transduction pathways via growth factor receptors, cytoplasmic protein kinases, and DNA binding transcription factors; modulate cell cycle proteins, and inhibit apoptotic pathways. In this review, we present an up-to-date overview on the use of nanomaterials for regulating viral proteins and oral cancer as well as the role of phytocompounds on oral cancer. The targets linking oncoviral proteins and oral carcinogenesis were also discussed.

Keywords: Bioactive compounds; Nanomaterials; Oncoviruses; Oral squamous cell carcinomas; Signaling pathways.

Publication types

  • Review

MeSH terms

  • Epstein-Barr Virus Infections* / complications
  • Herpesvirus 4, Human / physiology
  • Humans
  • Mouth Neoplasms* / therapy
  • Retroviridae
  • Risk Factors